Adiposity in children born small for gestational age

L Tappy1

  • 1Department of Physiology, University of Lausanne, Lausanne, Switzerland; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland. Luc.Tappy@unil.ch

Insights

Children born small for gestational age (SGA) face higher risks of adult metabolic and cardiovascular diseases. Early life nutrition and growth significantly impact long-term health outcomes, influencing disease susceptibility.

Area of Science:

  • Developmental biology
  • Metabolic disorders
  • Public health

Background:

  • Epidemiological studies link small for gestational age (SGA) birth to increased adult metabolic and cardiovascular disease risk.
  • The thrifty phenotype hypothesis suggests fetal undernutrition causes permanent metabolic changes, predisposing individuals to disease later in life.
  • This association extends beyond fetal undernutrition to include premature birth and high birth weight, with postnatal nutrition and catch-up growth also playing a role.

Purpose of the Study:

  • To explore the long-term metabolic and cardiovascular consequences of early life growth patterns.
  • To investigate the mechanisms underlying metabolic alterations in individuals born SGA.
  • To understand how fetal and early postnatal nutrition influence later health.

Main Methods:

  • Review of epidemiological studies on SGA and adult health outcomes.
  • Examination of animal models of intrauterine growth retardation (IUGR) to study glucose homeostasis.
  • Analysis of human studies assessing insulin resistance, glucose metabolism, and body composition in SGA individuals.

Main Results:

  • Animal models of IUGR exhibit altered glucose homeostasis, including reduced beta-cell mass and insulin secretion.
  • Human studies confirm insulin resistance in adolescents and young adults born SGA.
  • SGA children show early pubertal alterations in glucose homeostasis, increased lipid oxidation, altered stature, and increased fat mass, contributing to insulin resistance.

Conclusions:

  • Fetal and early neonatal nutrition ('metabolic imprinting') can induce permanent metabolic changes.
  • Mechanisms may involve gene expression modulation (e.g., DNA methylation), organ structure alterations, or long-lasting changes in hormonal axes.
  • These early-life events establish a 'thrifty phenotype' that increases susceptibility to metabolic and cardiovascular disorders in adulthood.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...